KALV (KalVista Pharma) Sof foyda

KALV (KalVista Pharmaceuticals, Inc.) - kompaniyaning tovar belgisi

KalVista Pharmaceuticals (KALV) dozalash shakllarini ishlab chiqish va klinik sinovlarni tashqi pudratchilarga topshirib, irsiy angioedemani davolashda inyeksiyalardan tabletka shakllariga o'tishga e'tibor qaratmoqda. Kompaniya narxlarining harakati aks etgan ushbu grafik -0.21 ko'rsatkichini ifodalaydi. Emitentning pozitsiyasi eksklyuziv patentlar va orfan dori maqomi bilan himoyalangan bo'lib, bu esa ulkan R&D xarajatlari bilan birgalikda yangi ishtirokchilar uchun kirish to'sig'ini yaratadi.

KALV (KalVista Pharmaceuticals) Sof foyda tarixi 04.07.2022dan 21.06.2026gacha

KalVista Pharmaceuticals, Inc. (KALV) kompaniyasining tahliliy kesimlari va maʼlumotlar hisoboti

- narx va narxlar bo'yicha konsensus prognoz:
Aksiya kotirovkalari KalVista Corp|KALV - Tahlilchilar konsensus prognozi
- biznesning bozor baholash ko'rsatkichlari:
Bozor kapitallashuvi KalVista Corp|KALV - Kompaniyani butunlay sotib olishdagi haqiqiy narx
- balans kapitallashuvi bo'yicha ma'lumotlar:
Aksiyaning buxgalteriya qiymati KalVista Pharmaceuticals|KALV - Balans kapitallashuvi|Balans qiymatiga nisbatan bozor kapitallashuvi kalvista.com|KALV - Kompaniyaning jami aktivlari
- qarzlar va to'lov qobiliyati haqida ma'lumot:
Umumiy qarzning xususiy kapitalga nisbati KalVista Pharmaceuticals|KALV - Uzoq muddatli qarzning o'z kapitaliga nisbati|Qisqa muddatli qarzning o'z kapitaliga nisbati KalVista Pharma|KALV - Kompaniyaning umumiy qarzi|Balans kapitallashuviga qarzlar KalVista Corp|KALV - Kompaniyaning uzoq muddatli qarzi|Kompaniyaning qisqa muddatli qarzdorligi KalVista Pharmaceuticals|Shoshilinch likvidlik kalvista.com
- sof daromad va qiymat multiplikatorlari ko'rsatkichlari:
KALV - Kompaniyaning sof foydasi
Kompaniyaning jamlanma tahlili:KalVista Pharmaceuticals
KalVista Pharmaceuticals Inc asosiy tovari

Irsiy angioedema terapiyasi bo'yicha biofarmatsevtika kashfiyoti bo'lgan KalVista Pharmaceuticals (KALV) uchun ushbu ko'rsatkich uning noyob oral preparatlarining tijoratlashtirish samaradorligini aks ettiradi. Ushbu metrika umumiy daromadlar va barcha operatsion xarajatlar, jumladan, R&D xarajatlari o'rtasidagi farq sifatida hisoblanadi. Kompaniyaning sof daromadliligini tahlil qilish orqali investor ishlanmalar bosqichidan foyda olish bosqichiga o'tishni aniqlaydi. Pastga yo'naltirilgan egri chiziq xarajatlarning kritik darajada ortganligidan dalolat beradi, barqaror o'sish esa KalVista Pharmaceuticals (KALV) innovatsiyalarining bozor qiymatini tasdiqlaydi.

Asosiy raqobatchilar

Sof daromad argenx BVBA|BNTX (BioNTech SE) - Sof foyda|Sof foyda Abivax Pharma|Sof daromad ADMA (ADMA Biologics, Inc.)|PTGX (Protagonist Therapeutics, Inc.) - Yakuniy foyda|Sof foyda IMVT (Immunovant Corp)|Sof moliyaviy natija Kiniksa Corp (KNSA)|GRFS - Kompaniyaning sof foydasi|adaptivebiotech.com (ADPT) - Sof daromad|Celldex Therapeutics, Inc. (CLDX) - Kompaniyaning sof foydasi|Sof daromad Aurinia Pharmaceuticals Inc|Sof daromad BCRX|Sof foyda Vera Corp|Kompaniyaning sof foydasi Dianthus Therapeutics (DNTH)|pharvaris.com - Kompaniya foydasi|Sof foyda ABCL (AbCellera Biologics Inc)|Tourmaline Bio Inc (TRML) - Kompaniyaning sof daromadi|PGEN - Kompaniyaning sof foydasi|PHAR - Sof foyda|NKTR: Sof foyda|upstreambio.com (UPB) - Sof foyda|Kompaniyaning sof foydasi Zenas Biopharma|Kompaniyaning sof foydasi IMNM|Sof daromad GOSS (Gossamer Corp)|Kompaniyaning sof foydasi SEPN (Septerna Pharma)|Sof foyda PVLA (Pieris Pharmaceuticals)|Sof moliyaviy natija savarapharma.com (SVRA)|RIGL - Kompaniyaning sof foydasi|Sof moliyaviy natija AnaptysBio Inc ANAB|ATXS (Astria Pharma) - Sof daromad|ENGN: Soliqlar to‘langandan keyingi foyda|RAPT (RAPT Therapeutics, Inc.) - Sof foyda|Sof foyda Aerovate|Sof daromad ACRS (Aclaris Therapeutics, Inc.)|KYTX (Kyverna Therapeutics Inc.) - Yakuniy foyda|Kompaniyaning sof foydasi Tiziana Life Sciences PLC TLSA|CABA (Cabaletta Bio Inc) - Soliqdan keyingi foyda|Ventyx Biosciences - Sof foyda|Yakuniy foyda THTX (theratech.com)|AVTX: Sof foyda|Eledon Pharmaceuticals Inc. (ELDN) - Sof foyda|Kompaniyaning sof foydasi Agenus Inc|CLYM: Yakuniy foyda|Kompaniyaning sof foydasi Zura Bio Limited (ZURA)|Sof daromad atyrpharma.com ATYR|Sof foyda ADAG (Adagene Inc.)|Sof foyda ImageneBio IMA|Shattuck Therapeutics - Sof foyda|Equillium, Inc. (EQ) - Sof daromad|CNTB: Sof foyda|Kompaniyaning sof daromadi Immunic (IMUX)|Sof daromad ATRA|Sof foyda InflaRx GmbH|Sof daromad XFOR (X4 Pharma)|Soliqlar to‘langandan keyingi foyda ACET|Sof foyda CELU (Celularity)|Sof moliyaviy natija inmunebio.com (INMB)|Barinthus Biotherapeutics plc - Sof foyda|Kezar Life Sciences Inc. (KZR) - Sof daromad|SABS: Sof foyda|Akari Therapeutics, Plc (AKTX) - Sof foyda|Kompaniyaning sof foydasi Enlivex Therapeutics Ltd|Kompaniyaning sof foydasi QTTB|Kompaniyaning sof foydasi GeoVax (GOVX)|Sof moliyaviy natija Edesa Biotech Inc|Kompaniyaning sof foydasi iBio Corp IBIO|Sof foyda Carisma Therapeutics Inc CARM|XTL Biopharmaceuticals - Sof foyda|BOLT - Sof foyda|hcwbiologics.com (HCWB) - Kompaniyaning sof foydasi|APVO (Aptevo Therapeutics Inc.) - Kompaniyaning sof foydasi|Sof daromad AIM|Kompaniyaning sof foydasi ADTX|Kompaniyaning sof foydasi GRI Bio, Inc. (GRI)|XRTX: Soliqdan keyingi foyda|Sof foyda HIND (Vyome Holdings)|Yakuniy foyda REVB|Indaptus - Sof foyda|SCNI - Sof foyda|calcimedica.com (CALI) - Kompaniyaning sof foydasi|Affimed N.V. - Yakuniy foyda|Kompaniyaning sof foydasi Allakos Inc|Sof daromad HOOKIPA (HOOK)|Sof foyda IGMS|Sof foyda iTeos Pharma (ITOS)|Ocean Biomedical, Inc. - Sof daromad|Yakuniy foyda TCBP|Third Harmonic Bio, Inc. - Sof foyda